{
  "docId": "019dd923-622c-750b-8b9a-2a2468219173",
  "docSlug": "ce565b841c40",
  "documentTitle": "Nevro Corp. (NVRO)",
  "authorId": "58_Scorpion_Capital",
  "authorName": "Kir Kahlon",
  "documentKindSlug": "activist-deck",
  "documentKindLabel": "Activist deck",
  "sourceTypeSlug": "short_seller",
  "sourceTypeLabel": "Short seller",
  "presentationDate": "2021-01-07 00:00:00",
  "orientation": "landscape",
  "aspectRatio": 1.3333334,
  "pageNumber": 89,
  "pageCount": 239,
  "prevPage": 88,
  "nextPage": 90,
  "slideType": "expose_contradiction",
  "function": "expose_contradiction",
  "density": "overcrowded",
  "nDataPoints": 1,
  "notes": "Uses testimonial-style quotes to build a narrative of corporate deception regarding product failure rates.",
  "elementsJson": [
    "headline_text",
    "paragraph",
    "bullet_list",
    "quote_block",
    "footnote"
  ],
  "metadataConfidence": 1,
  "imagePath": null,
  "slideHref": "/slides/019dd923-622c-750b-8b9a-2a2468219173/89",
  "deckHref": "/decks/019dd923-622c-750b-8b9a-2a2468219173",
  "deckJsonHref": "/decks/019dd923-622c-750b-8b9a-2a2468219173.json",
  "deckAnchorHref": "/decks/019dd923-622c-750b-8b9a-2a2468219173#slide-89",
  "components": [
    {
      "bbox": null,
      "kind": "callout",
      "text": "We believe Nevro sales hit the wall because of a covered-up explants crisis, and that fatal flaws specific to its high frequency mechanism of action are an albatross that dooms its trajectory.",
      "attrs": null,
      "subkind": null,
      "toolName": "Visual emphasis",
      "toolSlug": "visual-emphasis",
      "confidence": null,
      "componentId": "019dd953-3f3d-76db-b33d-8f1c155f7684",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.05,
        "w": 0.88,
        "x": 0.06,
        "y": 0.38
      },
      "kind": "list",
      "text": "A KOL in Europe, with extensive experience implanting Nevro’s devices, stated that the company’s device failure rate is common knowledge in Europe, where Nevro launched several years before the US.",
      "attrs": null,
      "subkind": "bullet",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "118c27fb-52cc-462b-b52f-3db950087383",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.05,
        "w": 0.88,
        "x": 0.06,
        "y": 0.65
      },
      "kind": "list",
      "text": "US KOL’s stated that Nevro was lying about it explant rate, that “everyone” thinks its high, and that the rate was “talked about at every meeting.”",
      "attrs": null,
      "subkind": "bullet",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "dc0ba540-e603-42d4-833b-b6516ce19332",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.13,
        "w": 0.88,
        "x": 0.06,
        "y": 0.13
      },
      "kind": "paragraph",
      "text": "The 33% explant rate found in the NANS paper was corroborated by one KOL after another during our 20+ research interviews with doctors...",
      "attrs": null,
      "subkind": "paragraph",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "c4834623-3e8f-4d15-a84e-90dcb1b37415",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.03,
        "w": 0.65,
        "x": 0.11,
        "y": 0.73
      },
      "kind": "quote",
      "text": "The Nevro marketing materials that state a 2% explant rate are just a flat out lie.",
      "attrs": null,
      "subkind": "testimonial",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "32c333a4-d289-461f-9c4f-2586769f0468",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.13,
        "w": 0.83,
        "x": 0.11,
        "y": 0.46
      },
      "kind": "quote",
      "text": "A lot of doctors in Germany are saying that Nevro’s device only works for 2 to 2 ½ years and then the patient comes back with more pain. They say it fails and then they have to put in an Abbott or Boston Scientific device. It’s a big issue here in Germany. These are credible people. People who do a lot of surgeries and are involved with the society. Every time there’s a spinal cord stim meeting, this is an issue that colleagues talk about. People have become nervous and become afraid to use Nevro.",
      "attrs": null,
      "subkind": "testimonial",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "6e533423-f676-4b9e-8c8b-db00bb092ef0",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.03,
        "w": 0.45,
        "x": 0.11,
        "y": 0.78
      },
      "kind": "quote",
      "text": "Everyone thinks Nevro has a high explant rate.",
      "attrs": null,
      "subkind": "testimonial",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "8a5b8614-ad3f-4afc-bc94-193e3ac55a9c",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.07,
        "w": 0.83,
        "x": 0.11,
        "y": 0.83
      },
      "kind": "quote",
      "text": "The Nevro explant rate was known all over. At every meeting, colleagues talked about the explant rate being high. [KOL name redacted] explants a bunch of Nevro a week. He was a big Nevro advocate and has a lot of explants. Everyone was drinking the Nevro kool-aid at the beginning.",
      "attrs": null,
      "subkind": "testimonial",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "d83b8853-bcac-49bd-9481-b60f16dda073",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": null,
      "kind": "quote",
      "text": "A lot of doctors in Germany are saying that Nevro's device only works for 2 to 2 ½ years and then the patient comes back with more pain. They say it fails and then they have to put in an Abbott or Boston Scientific device. It's a big issue here in Germany. These are credible people. People who do a lot of surgeries and are involved with the society. Every time there's a spinal cord stim meeting, this is an issue that colleagues talk about. People have become nervous and become afraid to use Nevro. — High volume European implanter; The Nevro marketing materials that state a 2% explant rate are just a flat out lie. — High volume KOL; Everyone thinks Nevro has a high explant rate. — High volume implanter; The Nevro explant rate was known all over. At every meeting, colleagues talked about the explant rate being high. [KOL name redacted] explants a bunch of Nevro a week. He was a big Nevro advocate and has a lot of explants. Everyone was drinking the Nevro kool-aid at the beginning. — KOL, high volume implanter",
      "attrs": null,
      "subkind": null,
      "toolName": "Authority citation",
      "toolSlug": "authority-citation",
      "confidence": null,
      "componentId": "019dd953-3f3d-76db-b33d-90e903be86af",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.02,
        "w": 0.2,
        "x": 0.06,
        "y": 0.95
      },
      "kind": "source-note",
      "text": "Source: Consultation calls with experts",
      "attrs": null,
      "subkind": null,
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "74f57a9d-c41e-43a1-bd83-13467c653780",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.02,
        "w": 0.45,
        "x": 0.06,
        "y": 0.09
      },
      "kind": "title",
      "text": "6. A covered-up device failure and explants crisis",
      "attrs": null,
      "subkind": "action-title",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "919d4bf1-62de-4027-8ae3-beabaf5ffc9c",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.03,
        "w": 0.35,
        "x": 0.06,
        "y": 0.04
      },
      "kind": "title",
      "text": "Scorpion Capital | Nevro (NYSE: NVRO)",
      "attrs": null,
      "subkind": "headline",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "d52939e8-e6d1-4872-bf6f-76346f33d474",
      "frameworkName": null,
      "frameworkSlug": null
    }
  ],
  "metrics": [],
  "tools": [],
  "frameworks": [
    {
      "name": "fraud-exposure",
      "slug": null,
      "matchId": "494a77f8-080f-497b-98dc-280d64f65022",
      "evidence": "The slide explicitly frames the company's reported data as a 'lie' and 'covered-up' crisis.",
      "confidence": 0.9
    }
  ],
  "arcBeats": [
    {
      "to": 150,
      "from": 51,
      "beatId": "903c076a-f368-4ca1-844c-277874c1afb2",
      "arcName": "Overcoming the Monster",
      "arcSlug": "overcoming-monster",
      "beatName": "The Victory",
      "beatSlug": "overcoming-monster-the-victory",
      "evidence": "The deck presents a conclusion that Nevro's problems are insurmountable",
      "position": 2,
      "confidence": 0.8,
      "parentBeatName": "Turn",
      "parentBeatSlug": "turn"
    }
  ],
  "loops": [],
  "imagePathAlt": null,
  "thumbSrc": null,
  "thumbSrcAlt": null,
  "locked": true
}